Author: Yang, Li; Liu, Shasha; Liu, Jinyan; Zhang, Zhixin; Wan, Xiaochun; Huang, Bo; Chen, Youhai; Zhang, Yi
Title: COVID-19: immunopathogenesis and Immunotherapeutics Cord-id: 3sh87h2x Document date: 2020_7_25
ID: 3sh87h2x
Snippet: The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected patients worldwide. The host immune response to SARS-CoV-2 appears to play a critical role in disease pathogenesis and clinical manifestations. SARS-CoV-2 not only activates antiviral immune responses, but can also cause uncontrolled inflammatory responses characterized by marked pro-inflammatory cytokine release in patients with
Document: The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected patients worldwide. The host immune response to SARS-CoV-2 appears to play a critical role in disease pathogenesis and clinical manifestations. SARS-CoV-2 not only activates antiviral immune responses, but can also cause uncontrolled inflammatory responses characterized by marked pro-inflammatory cytokine release in patients with severe COVID-19, leading to lymphopenia, lymphocyte dysfunction, and granulocyte and monocyte abnormalities. These SARS-CoV-2-induced immune abnormalities may lead to infections by microorganisms, septic shock, and severe multiple organ dysfunction. Therefore, mechanisms underlying immune abnormalities in patients with COVID-19 must be elucidated to guide clinical management of the disease. Moreover, rational management of the immune responses to SARS-CoV-2, which includes enhancing anti-viral immunity while inhibiting systemic inflammation, may be key to successful treatment. In this review, we discuss the immunopathology of COVID-19, its potential mechanisms, and clinical implications to aid the development of new therapeutic strategies against COVID-19.
Search related documents:
Co phrase search for related documents- aberrant host and acute lung injury: 1, 2, 3
- aberrant host and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- aberrant host and adaptive immune system: 1
- aberrant host inflammatory response and acute ards respiratory distress syndrome: 1, 2
- aberrant host inflammatory response and acute respiratory syndrome: 1, 2
- abnormal liver function and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver function and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver function and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- accurate sars diagnostic tool and acute respiratory syndrome: 1
- acute ards respiratory distress syndrome and adaptive immune system: 1, 2, 3, 4
- acute ards respiratory distress syndrome and adaptive immune system response: 1
- acute ards respiratory distress syndrome and ade antibody dependent enhancement: 1, 2
- acute ards respiratory distress syndrome and administer tocilizumab: 1
- acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
- acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and low cytokine level: 1
- acute lung injury and adaptive immune system: 1, 2, 3
- acute lung injury and adaptive immune system response: 1
- acute lung injury and ade antibody dependent enhancement: 1
Co phrase search for related documents, hyperlinks ordered by date